Company profile
Activirosomes Limited is a UK company with status active founded in 2017 based in East of England.
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Apr 2022 to 31 Mar 2023
Chikungunya virus is prevalent in more than 200 countries worldwide. Although infection causes illness that is usually non-lethal, it is responsible for development of arthralgia which leaves patient(s) debilitated and sometimes permanently unable to work or perform day-to-day functions. Thus it affects quality of life and causes significant economic loss...
1 Apr 2019 to 30 Jun 2019
"Activirosomes develops effective, affordable vaccines to respond quickly to new infection outbreaks and to prevent and protect against serious illnesses in humans and other animals. We have developed a series of Active Virosomes (AV) vaccines to pre-clinical proof of concept stage: we demonstrated that they are immunogenic and create a protective effect ...
1 May 2017 to 30 Apr 2018
This project demonstrates pre-clinical proof of “Active Virosome Vaccines” for prevention of Chikungunya, Zika and Ebola virus infections. It will not only produce new, inherently safe, low cost and easy to produce vaccine agents for prevention of these infections and so suitable for responding quickly to outbreaks of these and other viral diseases, inclu...
